# China NMPA Drug Inspection - Shenzhen Hepalink Pharmaceutical Co., Ltd. - Cefixime dry suspension

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/shenzhen-hepalink-pharmaceutical-co-ltd/931ae3ef-0cb4-46a6-bc06-225534904d72/
Source feed: China

> China NMPA drug inspection for Shenzhen Hepalink Pharmaceutical Co., Ltd. published September 21, 2018. Drug: Cefixime dry suspension. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Jiangxi Province 2018 Drug Quality Bulletin
- Company Name: Shenzhen Hepalink Pharmaceutical Co., Ltd.
- Publication Date: 2018-09-21
- Drug Name: Cefixime dry suspension

Company: https://www.globalkeysolutions.net/companies/shenzhen-hepalink-pharmaceutical-co-ltd/73ab214e-7ba7-4484-bce3-4bf799bfa729/